| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.1 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |